SCHEMBL765886

SCHEMBL765886

COC(=O)[C@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL86348 1.00 — —
SCHEMBL295130 1.00 — —
Hydrochloric Acid SCHEMBL722401 0.97 — —
SCHEMBL7105090 0.80 SMN1; SMN2 (0.46) —
SCHEMBL28353496 0.80 TSHR (0.37) —
SCHEMBL24072865 0.80 SMN1; SMN2 (0.46) —
SCHEMBL1557617 0.80 SMN1; SMN2 (0.46) —
SCHEMBL6744299 0.79 — —
SCHEMBL12447225 0.79 — —
Methyl 2-Methylbutanoate SCHEMBL1195352 0.79 TDP1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115657360-A Multicolor liquid crystal writing device and preparation method 山东蓝贝思特教装集团股份有限公司 2023-01-31 — — CN claimed
CN-111423393-A Synthetic method of seventeen-membered large cyclic lipopeptide natural compound 北京大学深圳研究生院 2020-07-17 — — CN claimed
CN-110467530-A A kind of Robison ester ((R)-(-) -3- hydroxy-2-methyl methyl propionate) and its derivative and its synthetic method SHANGHAI MUSE HEALTH TECH CO LTD 2019-11-19 — — CN claimed
US-12624051-B2 Macrocyclic compounds, compositions, and methods of using thereof GENZYME CORPORATION (US) 2026-05-12 — — US disclosed
CN-122011012-A (S) -tert-butyl ((2-methyl-7- (trimethylsilyl) hept-6-alkyne-1-yl) oxy) diphenyl silane and synthesis method and application thereof 山东省农业科学院 2026-05-12 — — CN disclosed
US-12545684-B2 CDK2 inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2026-02-10 — — US disclosed
US-20260008785-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SCHRODINGER, LLC 2026-01-08 — — US disclosed
US-20260008786-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SCHRODINGER, LLC 2026-01-08 — — US disclosed
EP-4656240-A1 NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER Novartis AG (CH) 2025-12-03 — — EP disclosed
EP-4646416-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 — — EP disclosed
EP-4646414-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2025-11-12 — — EP disclosed
US-5397775-A 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1995-03-14 — — US disclosed
EP-0331524-B1 SYNTHESIS OF TRICHOSTATINS Japan Tobacco Inc. (JP) 1993-08-18 — — EP disclosed
EP-0549318-A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1993-06-30 — — EP disclosed
EP-0520292-A1 Chiral azetidinone derivatives and their use as dopants in liquid crystalline mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-30 — — EP disclosed
EP-0251408-B1 NOVEL ANTI-INFLAMMATORY AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION THE PROCTER & GAMBLE COMPANY (US) 1991-04-17 — — EP disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 — — US disclosed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 — — EP disclosed
EP-0251408-A1 Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation THE PROCTER & GAMBLE COMPANY (US) 1988-01-07 — — EP disclosed
US-4708966-A SUBSTITUTED DI-TERT-BUTYL PHENOL DERIVATIVES THE PROCTER & GAMBLE COMPANY (US) 1987-11-24 — — US disclosed
Send feedback